Chemotherapy-induced neuropathiesa growing problem for patients and health care providers

被引:132
|
作者
Banach, Marta [1 ]
Juranek, Judyta K. [2 ,3 ]
Zygulska, Aneta L. [4 ]
机构
[1] Jagiellonian Univ, Coll Med, Dept Neurol, Krakow, Poland
[2] NYU, Dept Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA
[3] Univ Warmia & Mazury, Fac Med Sci, Dept Pathol, Olsztyn, Poland
[4] Jagiellonian Univ, Univ Hosp, Dept Oncol, Krakow, Poland
来源
BRAIN AND BEHAVIOR | 2017年 / 7卷 / 01期
关键词
chemotherapy-induced neuropathies; drug neurotoxicity; neuropathy risk factors; INDUCED PERIPHERAL NEUROPATHY; PLACEBO-CONTROLLED TRIAL; OXALIPLATIN-INDUCED NEUROPATHY; SMALL FIBER NEUROPATHY; QUALITY-OF-LIFE; DOUBLE-BLIND; MULTIPLE-MYELOMA; CANCER-PATIENTS; COLORECTAL-CANCER; OVARIAN-CANCER;
D O I
10.1002/brb3.558
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
IntroductionChemotherapy-induced neuropathies are one of the most common side effects of cancer treatment, surpassing bone marrow suppression and kidney dysfunction. Chemotherapy effects on the nervous system vary between different classes of drugs and depend on specific chemical and physical properties of the drug used. The three most neurotoxic classes of anti-cancer drugs are: platinum-based drugs, taxanes, and thalidomide and its analogs; other, less neurotoxic but also commonly used drugs are: bortezomib, ixabepilone, and vinca alkaloids. MethodsHere, in this paper, based on our experience and current knowledge, we provide a short review of the most common, neuropathy-inducing anti-cancer drugs, describe the most prevalent neuropathy symptoms produced by each of them, and outline preventive measures and treatment guidelines for cancer patients suffering from neuropathy and for their health care providers. ResultsPatients should be encouraged to report any signs of neuropathic pain, alteration in sensory perception, tingling, numbness, burning, increased hot/cold sensitivity and motor dysfunctions as early as possible. If known neurotoxic chemotherapeutics are used, a neurological examination with electrophysiological evaluation should be implemented early in the course of treatment so, both patients and physicians would be better prepared to cope with possible neurotoxic effects. ConclusionsThe use of neurotoxic chemotherapeutics should be closely monitored and if clinically permitted, that is, if a patient shows signs of cancer regression, drug doses should be reduced or combined with other less neurotoxic anti-cancer medication. If not counteractive, the use of over the counter antineuropathic supplements such as calcium or magnesium might be encouraged. If physically possible, patients should also be encouraged to exercise regularly and avoid factors that might increase nerve damage such as excessive drinking, smoking, or sitting in a cramped position.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers
    Stoehr, Jenna R.
    Kosche, Cory
    Choi, Jennifer N.
    [J]. SUPPORTIVE CARE IN CANCER, 2020, 28 (06) : 2887 - 2890
  • [2] Permanent chemotherapy-induced alopecia: awareness and attitudes among health care providers
    Jenna R. Stoehr
    Cory Kosche
    Jennifer N. Choi
    [J]. Supportive Care in Cancer, 2020, 28 : 2887 - 2890
  • [3] Knowledge and attitudes of permanent chemotherapy-induced alopecia among health care providers.
    Stoehr, Jenna Rose
    Kosche, Cory
    Choi, Jennifer N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (31)
  • [4] Knowledge and attitudes of permanent chemotherapy-induced alopecia among health care providers.
    Stoehr, Jenna Rose
    Kosche, Cory
    Choi, Jennifer N.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [5] The Clinical Problem of Chemotherapy-Induced Nausea and Vomiting
    Rapoport, Bernardo
    [J]. ONCOLOGY-NEW YORK, 2016, 30 (08): : 763 - 764
  • [6] Approach the prevention of chemotherapy-induced nausea and vomiting in older patients with care
    Connie Kang
    [J]. Drugs & Therapy Perspectives, 2022, 38 : 483 - 488
  • [7] Approach the prevention of chemotherapy-induced nausea and vomiting in older patients with care
    Kang, Connie
    [J]. DRUGS & THERAPY PERSPECTIVES, 2022, 38 (11) : 483 - 488
  • [8] Home care versus hospital care of patients with hematological malignancies and chemotherapy-induced cytopenia
    van Tiel, FH
    Harbers, MM
    Kessels, AG
    Schouten, HC
    [J]. ANNALS OF ONCOLOGY, 2005, 16 (02) : 195 - 205
  • [9] Chemotherapy-Induced Hepatotoxicity in HIV Patients
    Bressan, Silvia
    Pierantoni, Alessandra
    Sharifi, Saman
    Facchini, Sergio
    Quagliarello, Vincenzo
    Berretta, Massimiliano
    Montopoli, Monica
    [J]. CELLS, 2021, 10 (11)
  • [10] Exploring the Experiences of Cancer Patients With Chemotherapy-Induced Ototoxicity: Qualitative Study Using Online Health Care Forums
    Pearson, Stephanie E.
    Taylor, John
    Hoare, Derek J.
    Patel, Poulam
    Baguley, David M.
    [J]. JMIR CANCER, 2019, 5 (01):